相关实验视频
Updated: Jun 2, 2025

11:29
A Modified Method for Heterotopic Mouse Heart Transplantion
Published on: June 23, 2014
12.0K
心脏移植等候名单上的种族和民族差异
Ahad Firoz1, Daniel Remer2, Huaqing Zhao3
1Department of Internal Medicine, University of California Davis Medical Center, Sacramento, CA, United States of America.
International journal of cardiology
|January 15, 2025
概括
在心脏移植 (HTx) 等候名单结果中,种族差异仍然存在. 黑人和西班牙裔患者接受移植的几率较低,尽管黑人患者的等待名单死亡率最近有所下降.
科学领域:
- 心脏病学 心脏病学
- 移植医学 移植医学
- 健康 公平 卫生 公平
背景情况:
- 种族差异在美国显著影响心脏移植 (HTx).
- 虽然研究了移植后生存不平等,但等候名单结果数据有限且相互矛盾.
- 这项研究分析了跨种族和种族群体的心脏移植等待名单上的死亡率和移植率.
研究的目的:
- 调查心脏移植 (HTx) 等候名单死亡率的种族和种族差异.
- 分析接受心脏移植 (HTx) 的几率的种族和种族差异.
- 评估HTx等待列表结果的趋势随着时间的推移和政策变化后.
主要方法:
- 从2000年1月1日至2023年9月9日,使用UNOS数据库对成年患者进行心脏移植 (HTx) 的分析.
- 纳入标准侧重于那些认为自己是白人,黑人,西班牙裔或亚裔的患者.
- 排除以前有HTx,并发肺清单,异型或多器官移植的患者. 分析了等候名单死亡率和移植几率.
主要成果:
- 在HTx等候名单上,黑人和西班牙裔患者的比例增加;亚洲比例保持稳定,白人比例下降.
- 黑人患者在21世纪初表现出更高的等候名单死亡率,这一风险在过去十年里变得可以忽略不计.
- 黑人和西班牙裔患者的移植几率始终显著降低,即使在新的分配政策实施后也持续存在.
结论:
- 在心脏移植 (HTx) 列表过程中,黑人和西班牙裔患者的显著差异仍然存在.
- 解决偏见意识,增加评估团队的多样性,解决健康的社会决定因素对于改善结果至关重要.
- 需要继续努力,确保所有种族和族裔群体平等获得心脏移植 (HTx).
相关概念视频
Tissue Transplantation
337
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
337
Bone Marrow Sampling and Transplants
277
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
277

